About This Research Study
Chronic liver disease encompasses a range of conditions that can cause ongoing liver damage over time. Many forms of chronic liver disease are characterized by the buildup of fat in the liver (steatosis), inflammation, and scarring (fibrosis), which can progress and impair liver function if left untreated. Tekton Research is currently enrolling participants in a clinical study evaluating an investigational medication for steatotic liver disease and advanced fibrosis. Eligible participants may be compensated up to $1,500 for study-related time and travel expenses.
Eligible participants…
- Must be age 18 or older
- Must be diagnosed with Steatotic Liver Disease (SLD)
- Must have a BMI of 25 kg/m² or greater
- Must have stable body weight for the last 3 months
- Must NOT have had any type of bariatric surgery
- May receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Tekton enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.